Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated (CORT) Stock Overview

Explore Corcept Therapeutics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

CORT●NASDAQ
HealthcareMedical - Pharmaceuticals
$113.76
$3.47(3.15%)
U.S. Market opens in 3h 35m

Corcept Therapeutics Incorporated (CORT)

Meyka AI Score

Z

Key Financials

Market Cap12.3B
P/E Ratio221.02
EPS (TTM)$0.35
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$110.13
3 Months$89.64
1 Year Target$76.89

CORT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Corcept Therapeutics Incorporated (NASDAQ: CORT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Corcept Therapeutics Incorporated's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CORT on the NASDAQ shows an RSI of 52.27, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $76.89 for the NASDAQ listing.

Key metrics behind Corcept Therapeutics Incorporated's NASDAQ-traded stock include a P/E ratio of 221.02 and a market capitalization of 12.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CORT on the NASDAQ.

Price Performance (NASDAQ: CORT)

1-Day Change
3.15%
5-Day Change
2.65%
1-Month Change
-6.94%
3-Month Change
42.72%
6-Month Change
228.41%
Year-to-Date (YTD) Change
226.90%
1-Year Change
42.20%
3-Year Change
256.28%
5-Year Change
461.78%
All-Time (Max) Change
830.17%

Contact Information

https://www.corcept.com
650 327 3270
101 Redwood Shores Parkway, Redwood City, CA, 94065

Company Facts

7,300 Employees
IPO DateApr 14, 2004
CountryUS
Actively Trading

Frequently Asked Questions